SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Dadx4
Search This Board:
Last Post: 1/17/2017 3:49:36 PM - Followers: 325 - Board type: Free - Posts Today: 0


     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact: [email protected]
Media Contact: [email protected]

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan) 12/14/2016 08:05:00 AM
ONVO News: Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting 12/13/2016 08:05:00 AM
ONVO News: Organovo to Present at 28th Annual Piper Jaffray Healthcare Conference 11/22/2016 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:11:40 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:09:58 PM
#9723  Sticky Note Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan) Dadx4 12/14/16 08:25:51 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9776   More reasons to go up than down - WHP03 01/17/17 03:49:36 PM
#9775   100% Agree.... I watch the CCI closely. WHP03 01/17/17 03:49:13 PM
#9774   It must hold $3.50 though IMO. rayank 01/17/17 01:41:37 PM
#9773   Appears poised for take-off, for sure. Bought more pupuguru 01/17/17 01:09:17 PM
#9772   Bollinger bands are getting tighter and tighter. Current Ballgame 01/16/17 04:24:12 PM
#9771   I've been trying to buy more calls today Ballgame 01/13/17 12:48:53 PM
#9770   I like that also, and I do see rayank 01/13/17 12:04:08 PM
#9769   Getting pretty close to that golden cross. That's Ballgame 01/13/17 10:17:31 AM
#9768   I have sold Puts in every month rongreen 01/08/17 09:54:23 AM
#9767   I have been selling $3.50 puts my latest dds2th 01/07/17 11:50:50 PM
#9766   Some have suggested ONVO's long-term Mkt Cap could WHP03 01/07/17 12:55:33 PM
#9765   You are welcome. Yeah we need a 3rd rayank 01/07/17 07:13:03 AM
#9764   My sense is it's a restatement of Lavin WHP03 01/06/17 08:52:43 PM
#9763   It was a headline in my Ameritrade account rayank 01/06/17 06:20:13 PM
#9762   That's BTIG’s Sean Lavin's target ($5)... do you WHP03 01/06/17 06:10:22 PM
#9761   Thx "WHP03", appreciate your reply... wiredawg 01/06/17 05:56:33 PM
#9760 rayank 01/06/17 05:37:52 PM
#9759   Do you have a link to show Jefferies' WHP03 01/06/17 04:54:49 PM
#9758   I know one who has been very successful WHP03 01/06/17 04:39:01 PM
#9757   Agreed...for those truly long, this is the type wiredawg 01/06/17 02:05:58 PM
#9756   Jefferies Maintains Buy (NASDAQ: ONVO): Buy, $5 rayank 01/06/17 11:50:43 AM
#9755 Ballgame 01/06/17 10:46:44 AM
#9754   Yeah, you're right. Good call there. A Ballgame 01/06/17 10:45:24 AM
#9753   That's an automated process, and flips back and WHP03 01/05/17 04:47:01 PM
#9752   Only because it met its price target, or Ballgame 01/05/17 03:18:36 PM
#9751   On January 4, 2017 Zacks Investment Research, Inc. RandolRocketman 01/05/17 10:50:05 AM
#9750   Sorry S22. I missed this post and question. Dadx4 01/04/17 02:06:12 PM
#9749 also goes on to state that ONVO Ballgame 01/03/17 11:27:32 PM
#9748   This is very nice to see. I Ballgame 01/03/17 11:18:26 PM
#9747   ZACKS today (1 of 5 best): "Organovo Holdings rayank 01/03/17 04:31:22 PM
#9746   Yes I agree rayank 01/03/17 07:21:19 AM
#9745   I've been invested long with this one since Ballgame 01/02/17 10:03:02 PM
#9744   IMO, a longer play that could pay off rayank 01/02/17 12:18:53 PM
#9743   Hey stockmama22, phytokaiser1 01/02/17 10:54:29 AM
#9742   Hey DADX! I've been eyeing ONVO for awhile, stockmama22 12/30/16 04:44:25 PM
#9741   End of year tax write offs in losses Ballgame 12/30/16 12:41:11 PM
#9740   LOL - these guys ping pong back and WHP03 12/29/16 04:23:22 PM
#9739   Thomson Reuters/Verus upgrades ORGANOVO HOLDINGS INC from SELL RandolRocketman 12/29/16 09:59:32 AM
#9738   MERRY CHRISTMAS AND HAPPY HOLIDAYS TO ALL! Dadx4 12/24/16 12:45:29 PM
#9737   New article: "Will 2017 Be Organovo Holdings, Inc.'s rayank 12/24/16 12:42:09 PM
#9736   IBB performance didn't hurt either Ballgame 12/23/16 04:39:58 PM
#9735   Really nice support yesterday and today in only Ballgame 12/23/16 04:05:58 PM
#9734   nice dshade 12/23/16 02:43:58 PM
#9733   Closed <8-DAY EMA (T-line), which is 'ok', unless WHP03 12/21/16 04:19:13 PM
#9732   I agree. I like to use the 150 Ballgame 12/21/16 10:39:20 AM
#9731   $3.63 is the 8-DAY EMA. Would prefer WHP03 12/20/16 08:48:48 PM
#9730   I'm guessing a nice rsi reset before the Ballgame 12/20/16 02:13:27 PM
#9729   Yes wiredawg, I just posted that article word rayank 12/20/16 08:05:21 AM
#9728   The main problem with ONVO is debt...will they wiredawg 12/20/16 12:31:18 AM
#9727   Growing acceptance: People were once resistant but now rayank 12/19/16 02:56:26 PM